Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin for NTM Lung Disease
NCT00600769Phase 4Completed
- Sponsor
- The University of Texas Health Science Center at Tyler
- Start
- Jan 1991
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin in nontuberculous mycobacteria infection, Mycobacterium avium complex lung disease, sponsored by The University of Texas Health Science Center at Tyler. Started Jan 1991; status: completed.
02
Drugs
clarithromycin
03
Conditions
nontuberculous mycobacteria infectionMycobacterium avium complex lung disease
Beyond the preview
Go deeper on NCT00600769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600769.